ASPirin in Reducing Events in the Elderly (ASPREE)
ASPREE is the largest international trial ever funded by the US National Institute on Aging (NIA), enrolling 19,000 participants age 65 or older in the US and Australia, randomizing them to either daily low dose aspirin or placebo. This study will help answer questions as to whether or not daily aspirin use for people age 65+ can actually prolong independence and prevent cognitive decline.
The Berman Center is the US Coordinating Center for ASPREE in cooperation with Monash University in Melbourne, Australia and NIA.
For more information visit www.aspree.org
